{"disease":{"id":"dry-eye-syndrome","name":"dry eye syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03938207","title":"Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT04744805","title":"Mask-associated Dry Eye Symptoms in China","phase":"","overall_status":"UNKNOWN","enrollment_count":6262,"lead_sponsor_name":"Tianjin Eye Hospital","has_results":false},{"nct_id":"NCT03135327","title":"Clinical Applications of Advanced Ophthalmic Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT04747288","title":"Objective Measurement With TCM Pattern for AIDDES","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06499753","title":"Differences in Dry Eye Symptoms Related to Geographic Location in Spain and Impact of Artificial Tears Use","phase":"","overall_status":"COMPLETED","enrollment_count":1033,"lead_sponsor_name":"University of Valladolid","has_results":false},{"nct_id":"NCT03937882","title":"Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"ReGenTree, LLC","has_results":false},{"nct_id":"NCT05848128","title":"Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":642,"lead_sponsor_name":"Mimetogen Pharmaceuticals USA, Inc.","has_results":false},{"nct_id":"NCT03652415","title":"DRy Eye Outcome and Prescription Study","phase":"","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04206020","title":"Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"Mitotech, SA","has_results":true},{"nct_id":"NCT05201170","title":"A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":575,"lead_sponsor_name":"Palatin Technologies, Inc","has_results":false},{"nct_id":"NCT05096546","title":"The Proportion of Patients Diagnosed With Dry Eye by the Asia Dry Eye Society (ADES) Criteria in Taiwan (DECS-TW)","phase":"","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT04147650","title":"Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":508,"lead_sponsor_name":"Aurinia Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03764735","title":"Study of SkQ1 as Treatment for Dry-eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"Mitotech, SA","has_results":true},{"nct_id":"NCT05653921","title":"Prospective Study to Validate the Imaging Biomarker for NCP (R33)","phase":"","overall_status":"SUSPENDED","enrollment_count":438,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT04127851","title":"Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":438,"lead_sponsor_name":"Taejoon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02645045","title":"Evaluation of Factors Affecting the Tear-film Lipid Layer Thickness","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04674358","title":"The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":329,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03527212","title":"A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":329,"lead_sponsor_name":"Senju Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03223909","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":326,"lead_sponsor_name":"Laboratorios Sophia S.A de C.V.","has_results":true},{"nct_id":"NCT01459588","title":"Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01294384","title":"Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03404115","title":"A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT02767258","title":"Effect of Nursing Care on Prevention of Dry Eye","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Diego Dias de Araújo","has_results":false},{"nct_id":"NCT06388070","title":"To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"Huons Co., Ltd.","has_results":false},{"nct_id":"NCT04030962","title":"A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06427031","title":"Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":271,"lead_sponsor_name":"Taejoon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03982368","title":"A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":true},{"nct_id":"NCT05433428","title":"Metabolomic Profile in Dry Eye Syndrome Patients.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Ifocus Oyeklinikk","has_results":false},{"nct_id":"NCT02553772","title":"A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05017844","title":"[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Kukje Pharma","has_results":false},{"nct_id":"NCT06475027","title":"Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06771427","title":"Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT04343287","title":"Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"BRIM Biotechnology Inc.","has_results":true},{"nct_id":"NCT04384991","title":"HU007 Eye Drops in Patients With Dry Eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Huons Co., Ltd.","has_results":false},{"nct_id":"NCT03461575","title":"Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":209,"lead_sponsor_name":"Huons Co., Ltd.","has_results":false},{"nct_id":"NCT06240364","title":"Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":204,"lead_sponsor_name":"University of Alicante","has_results":false},{"nct_id":"NCT03833388","title":"Study of TOP1630 for Dry Eye Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Topivert Pharma Ltd","has_results":false},{"nct_id":"NCT06406933","title":"Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06089317","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03364322","title":"Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Hallym University Kangnam Sacred Heart Hospital","has_results":false},{"nct_id":"NCT06235450","title":"A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Olympic Ophthalmics, Inc.","has_results":false},{"nct_id":"NCT05598437","title":"Prevalence of Different Etiologies of Ocular Dryness in Patients Previously Diagnosed With Dry Eye Disease in A Sample of Egyptian Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Roweis adel youssef","has_results":false},{"nct_id":"NCT02280473","title":"A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT02910713","title":"Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation","phase":"NA","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03723798","title":"Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Samjin Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02446015","title":"Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye","phase":"NA","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT03066219","title":"Safety and Efficacy of BRM421 for Dry Eye Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"BRIM Biotechnology Inc.","has_results":false},{"nct_id":"NCT05456061","title":"Effect of ADDE on Tear Interferometry","phase":"NA","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT03723811","title":"Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Samjin Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06780293","title":"Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}